Cost-effective, comprehensive, personalized pharmacogenomic analysis — integrated into patients' everyday clinical care
Addressing the whole patient
The OneOme RightMed® pharmacogenomic test allows providers to make decisions across more than 340 medications for more than 20 medical indications.
The OneOme RightMed PGx interactive drug report tool allows providers to explore, filter, and generate custom reports with annotations and drug-drug interactions based on specific criteria or medical indications.
Curated, credible data
At OneOme, we continually curate our clinical PGx database, only adding drugs characterized by high levels of evidence from FDA drug labeling and the Clinical Pharmacogenetics Implementation Consortium (CPIC)1,2
Actionable, at-a-glance report
Designed to be useful and clear in real workflows, the OneOme RightMed PGx report informs targeted, timely, evidence-based decisions. Providers can easily identify optimal drug therapy for individual patients, making personalized treatment decisions.
The individual genetic results are analyzed by OneOme's proprietary algorithm, which takes into account the cumulative effect from each of the genotypes to provide a reproducible and consistent interpretation of pharmacogenomic data.
Based on the algorithmic analysis, the OneOme RightMed report categorizes drugs into a simple, scannable format:
Drug interactions can cause unwanted side effects, reduce the effectiveness of some medicines, and increase the action of others. The OneOme RightMed PGx interactive, custom drug report tool allows providers to:
filter and select
medications based on
medical condition and/or
patient medication history
search all medications
in the database
view detailed information
about any medication
This information can help a provider determine if currently prescribed medications may cause adverse interactions. Some drug-drug interactions can occur when there is induction or inhibition within the same family of drug metabolism enzymes.